[20] CHAPTER IX LESSON 2 Flashcards

1
Q

TYPES OF DEFERRAL

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prospective donor is unable to donate blood for a limited period of time

A

Temporary Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Donor has received a blood transfusion; defer for [?] from date of transfusion.

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Donor received vaccination for yellow fever; defer for [?] from date of vaccination.

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Active diseases under the treatment such as cold, flu, tuberculosis, syphilis, infections

A

Temporary Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

curable diseases of the heart, lungs, kidney, liver and gastrointestinal (GI) tract

A

Temporary Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

treatment with antibiotics

A

Temporary Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

An immigrant or refugee coming from an area considered endemic of malaria-

A

1 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • provided the donor showed no signs and symptoms of malaria infection with or without antimalarial prophylactic drug therapy.
A

1 year after departure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • immigrants, refugees, citizens, or persons who have resided in the endemic area for at least 5 consecutive years.
A

3 years from time of departure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Those who have had a diagnosis of malaria

A

3 years after becoming asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Leishmania risk
-Travel to Iraq in the last

A

3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Leishmania risk
-[?]deferral from last departure

A

12-month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

West Nile Virus (WNV)- [?]deferral from symptoms of headache with fever during defined risk season

A

120-day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

[?] from recovery with a clinical diagnosis or suspicion of WNV

A

120 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tattoo, permanent make-up, ear and body piercings

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sexual contact with a prostitute or other persons in a high-risk group for AIDS

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Incarceration in a jail for more than 72 consecutive hours

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Transfusion of blood / blood components

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Travel to areas endemic for malaria (with or without prophylactic therapy)

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Woman received a transfusion during her pregnancy

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

After hepatitis B immune globulin administration

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

After therapeutic rabies vaccination, rape victims, health workers with percutaneous exposure to blood or body fluids

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Close contact with viral hepatitis

A

1 year or 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

FDA mandates persons who have had sex with any person who is a past or present IV drug user should be deferred for

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

deferral from the last date of incarceration

A

12-month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

History of syphilis or gonorrhea: [?] after completion of therapy

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

T. pallidum may live for 1 to 5 days in cold storage, at RT, it thrives very well

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Following a delivery of a baby

A

For six weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

German measles (rubella) vaccination’

A

For 1 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

After cessation of the drug isotretinoin (accutane) and finasteride (proscar)

A

For 1 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Smallpox vaccination: 14-21 days or until the scab has fallen off

A

For 1 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Recent blood donation

A

For 2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

:  WB donation deferred after hemapheresis

A

For 48 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

:  Live attenuated vaccine for German measles (rubella)

A

For 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

After vaccination with oral polio, measles (rubeola)

A

For 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Mumps or yellow fever

A

For 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Prospective donor is unable to donate blood for someone else for an unspecified period of time due to current regulatory requirements.

A

Indefinite Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

This donor would not be able to donate blood until the current requirement changes.

A

Indefinite Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Theses donors may be eligible to donate autologous blood.

A

Indefinite Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Donor states they have lived in England for 1 year in 1989

A

Indefinite Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

History of chagas’ disease or babesiosis

A

Indefinite Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Received a dura mater graft

A

Indefinite Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

History of cancer, leukemia, or lymphoma

A

Indefinite Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Insulin from cows (bovine, or beef insulin)

A

Indefinite Deferral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Prospective donor will never be eligible to donate blood for someone else.

A

Permanent Deferral

47
Q

These donors may be eligible to donate autologous blood.

A

Permanent Deferral

48
Q

Some permanent deferrals may result from the testing performed on a previous donation.

A

Permanent Deferral

49
Q

Donor states that he or she has hepatitis C

A

Permanent Deferral

50
Q

High risk history of AIDS

A

Permanent Deferral

51
Q

men who have had sex with another man any time since 1977

A

Permanent Deferral

52
Q

hemophiliacs

A

Permanent Deferral

53
Q

intravenous drug abusers

A

Permanent Deferral

54
Q

persons who engaged in sex for money or drugs anytime since 1977

A

Permanent Deferral

55
Q

confirmed positive laboratory test for AIDS

A

Permanent Deferral

56
Q

symptoms of viral hepatitis after age 15

A

Permanent Deferral

57
Q

Positive tests for hepatitis C antibody (HCAb)

A

Permanent Deferral

58
Q

Confirmed positive test for human T cell lymphotropic virus (HTLV)

A

Permanent Deferral

59
Q

Malignant solid tumors (except for basal cell carcinoma of the skin and carcinoma in situ of the cervix)

A

Permanent Deferral

60
Q

Hematologic malignancies

A

Permanent Deferral

61
Q

Chemotherapeutic agents administered for malignancy

A

Permanent Deferral

62
Q

Chronic cardiopulmonary, liver, or renal disease

A

Permanent Deferral

63
Q

Serious abnormal bleeding tendencies

A

Permanent Deferral

64
Q

Drug etretinate (Tegison) for the treatment of psoriasis

A

Permanent Deferral

65
Q

Growth hormone from human pituitary glands

A

Permanent Deferral

66
Q

Prescribed for children with delayed or impaired growth

A

Growth hormone from human pituitary glands

67
Q

Hormone- obtained from human pituitary glands.

A

Growth hormone from human pituitary glands

68
Q

Causes a rare nervous system condition called “CJD- Creutzfeldt- Jakob Disease”

A

Growth hormone from human pituitary glands

69
Q

Toxoids or killed or synthetic viral, bacterial or rickettsial vaccines

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

70
Q

Diphtheria

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

71
Q

Hepatitis A and B

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

72
Q

Influenza

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

73
Q

Lyme disease

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

74
Q

Polio injection (Salk)

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

75
Q

Anthrax

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

76
Q

Cholera

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

77
Q

Paratyphoid

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

78
Q

Rabies

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

79
Q

Rocky mountain spotted fever

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

80
Q

Tetanus or typhoid injection

A

NO DEFERRAL (Provided that the donor is symptom free and afebrile)

81
Q

Key records, including dates, times and signatures, to be maintained and retained during the donor selection process

A

DONOR RECORDS

82
Q

DONOR RECORDS include:

A

o Donor registration information
o Completed donor questionnaires and informed consent
o Outcomes of donor interview and assessment
o Donor deferral records
o Unique donation number for each donation
o Donor counselling and follow-up records
o Adverse donor events and reactions
o Donor deferral registry

83
Q

also enable the previous deferral status of donors to be checked and decisions made on the re-entry of temporarily deferred donors.

A

Donor deferral records

84
Q

Is a confidential list of donors who are positive for a transfusiontransmissible infection and who have been permanently deferred

A

donor deferral registry (DDR) i

85
Q

is used to monitor the incidence and prevalence of such infections in the donor population and may also assist in identifying areas that require strengthening in the donor selection process.

A

donor deferral registry (DDR)

86
Q

Blood banks use various processes to try to prevent infections that can be transmitted by infected blood donation.

A

EQUIPMENTS/MATERIALS FOR BLOOD CONNECTION

87
Q

The process for collecting blood from donors is similar to that used for blood sampling; however, a few additional measures are required for collection of donated blood.

A

EQUIPMENTS/MATERIALS FOR BLOOD CONNECTION

88
Q

Proper materials and equipment are necessary to ensure patient safety and proper blood collection.

A

EQUIPMENTS/MATERIALS FOR BLOOD CONNECTION

89
Q

Such equipment includes blood pressure monitors, scales, donor couches or chairs, blood collection monitors or mixers, blood bag tube sealers, blood transportation boxes and blood bank refrigerators.

A

EQUIPMENTS/MATERIALS FOR BLOOD CONNECTION

90
Q

Common blood donation materials and equipment:

A
91
Q

makes the donor comfortable during blood collection

A

Blood donation chair

92
Q

provides support to the body in various conditions

A

Blood donation chair

93
Q

supposedly configured to conform to the new Gold Standard Clinical Pathway for Blood Donation

A

Blood donation chair

94
Q

are designed for the collection, processing and storage of whole blood and blood components

A

Blood bags

95
Q

help in providing aseptic conditions for the separation of blood components

A

Blood bags

96
Q

-Reduces over and under bleeds (QNS units)

A

Blood Collection Mixer

97
Q

Provides constant mixing of anticoagulant and blood

A

Blood Collection Mixer

98
Q

is a compact equipment to seal the PVC blood bag tubes or sets for cryopreservation

A

The Blood Bag Tube Sealer

99
Q

is an essential piece of equipment in the immunohematology department

A

blood bank refrigerator

100
Q

provides safe and convenient storage of whole blood, blood components (e.g., blood cells, plasma), and reagents

A

blood bank refrigerator

101
Q

ensure freshness and integrity of blood and blood components.

A

Blood bank refrigerators

102
Q

is to provide a maintained freezing temperature -30°C or -40°C for safe storage of fresh frozen plasma, red cells, cryoprecipitate and platelet concentrates

A

plasma freezer

103
Q

Each unit meets every guidance parameters and requirements for safe storage of blood plasma.

A

plasma freezer

104
Q

The platelets (thrombocytes) are stored in

A

platelet agitator

105
Q

The main function of the [?] is to store platelet concentrates in continuous horizontal motion at a specified temperature.

A

platelet agitator

106
Q

is a device used in blood donation that separates the platelets and returns other portions of the blood to the donor.

A

Platelet extractor

107
Q

is equipment designed for rapid and uniform thawing of fresh frozen plasma (FFP) bags at 37°C

A

Plasma Thawing Bath

108
Q

This device is made of a stainless steel chamber and equipped with digital temperature controller and a water circulating pump

A

Plasma Thawing Bath

109
Q

are used for samples that need a consistent range of temperature

A

Refrigerated centrifuges

110
Q

can also achieve speeds of over 30,000 rounds per minute with relative centrifugal force of over 65,000 x g

A

Refrigerated centrifuges

111
Q

may come in varying configurations such as the swing bucket, fixed angle or both

A

Refrigerated centrifuges

112
Q

The purpose of is to remove plasma, which contains substance that may interfere with antigen-antibody reaction.

A

Cell washer

113
Q

Programming flexibility allows the user to customize and save programs for repeated use and its unique features to win over conventional cell washing systems.

A

Cell washer